NORGES BANK - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$124,000
+34.8%
34,4470.0%0.00%
Q2 2019$92,000
-9.8%
34,4470.0%0.00%
Q1 2019$102,000
+85.5%
34,4470.0%0.00%
Q4 2018$55,000
-56.7%
34,4470.0%0.00%
Q3 2018$127,000
+24.5%
34,447
-5.0%
0.00%
Q2 2018$102,000
-24.4%
36,2610.0%0.00%
Q1 2018$135,000
-94.5%
36,261
-95.8%
0.00%
-100.0%
Q4 2017$2,468,000
-35.9%
857,0760.0%0.00%0.0%
Q3 2017$3,849,000
+78.3%
857,076
+82.2%
0.00%0.0%
Q2 2017$2,159,000
-39.8%
470,292
-44.8%
0.00%0.0%
Q1 2017$3,585,000
-22.5%
851,636
-23.9%
0.00%
-50.0%
Q4 2016$4,623,000
-46.6%
1,119,4960.0%0.00%
-50.0%
Q3 2016$8,660,000
+45.4%
1,119,496
+46.6%
0.00%
+33.3%
Q2 2016$5,958,000
+2139.8%
763,819
+2117.4%
0.00%
Q1 2016$266,000
-28.5%
34,4470.0%0.00%
Q4 2015$372,000
+56.3%
34,4470.0%0.00%
Q3 2015$238,000
-22.0%
34,4470.0%0.00%
Q2 2015$305,000
-10.3%
34,4470.0%0.00%
Q1 2015$340,000
-83.6%
34,447
-79.7%
0.00%
-100.0%
Q4 2014$2,079,000
+22.7%
169,7310.0%0.00%0.0%
Q3 2014$1,694,000169,7310.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders